Name: PATfix® Solutions
Brand: Sartorius
SKU: M_PATfix
Availability: OutOfStock

The PATfix^® system provides modality-appropriate analysis and in-process control for gene therapy and vaccine products. Designed to take full advantage of the capabilities of CIMac™ analytical monolithic columns, the PATfix^® delivers fast, high-resolution runs. Operation with multiple detector types provides content- rich analyses even with complex samples. User friendly PATfix^® software makes for easy data processing, visualization and sharing.

Availability:

PATfix® Solutions

Item No.:

M_PATfix

Availability:

Products (10)

PATfix® pDNA Platform

Documents

Rapid at-line analytical chromatography solution for all stages of pDNA processing.
PATfix^®pDNA is a biocompatible platform, engineered for pDNA isoform and multimer separation. Built around analytical capability of the CIMac^® pDNA monolithic columns, the pDNA platform includes user guides, validated methods, SOPs and pDNA standards and user-friendly PATfix^® software.

Item no.

PAT0029

Item no.

PAT0029
Column Thermostat

Documents

Temperature control system with heating and cooling

Item no.

PAT0030

Item no.

PAT0030
Fluorescence Detector

Documents

The perfect detector for analysis of complex samples via fluorescence selectivity

Item no.

PAT0023

Item no.

PAT0023
PATfix® analytical quaternary system

Documents

Biocompatible analytical chromatography system with quaternary buffer setup.
PATfix^® analytical quaternary system is an at-line tool, to help process developers of novel gene therapies get immediate feedback on their current process state. This enables faster iteration and process optimization towards better purities and higher recoveries. The Sartorius analytical system provides modality-appropriate analysis and in-process control for gene therapy and vaccine products. Designed to take full advantage of the capabilities of CIMac™ analytical monolithic columns, the PATfix^® delivers fast, high-resolution runs. Operation with multiple detector types provides content- rich analyses even with complex samples. User friendly PATfix^® software makes for easy data processing, visualization and sharing.

Item no.

PAT0021

Item no.

PAT0021
pDNA standard pFix15 sc/oc (250 µg)

Plasmid pFix15 standard is a 15.4 kb plasmid DNA isolated from E. coli and chromatographically purified. It is mainly intended for System Suitability Testing and preparation of a standard curve.

Item no.

BIA-PFIX15.1.1

Item no.

BIA-PFIX15.1.1
pDNA standard pFix5 sc/oc (250 µg)

Plasmid pFix5 standard is a 4.7 kb plasmid DNA isolated from E. coli and chromatographically purified. It is mainly intended for System Suitability Testing and preparation of a standard curve.

Item no.

BIA-PFIX5.1.1

Item no.

BIA-PFIX5.1.1
mRNA standard mFix4 4000nt (150 µg)

The mFix4 mRNA standard is a 3969 nt long mRNA molecule with a poly-adenylated tail of 95 nt. The molecule is produced by IVT reaction with a DNA template retrieved from recombinant microbial expression (E. coli). Its primary use is System Suitability Testing.

Item no.

BIA-MFIX4.1.1

Item no.

BIA-MFIX4.1.1
Fraction Collector

Documents

When additional sample characterization is required, the fraction collector allows for easy automation of sample collection, that can then be analysed offline in-depth.

Item no.

PAT0031

Item no.

PAT0031
PATfix® mRNA Platform

Documents

Rapid at-line analytical chromatography solution for all stages of mRNA production, purification and quality assesment. Gain immediate feedback on purities and recoveries during process development.
PATfix^® mRNA platform is the all-in-one solution when it comes to a wide array of mRNA analytics. It contains all the necessary hardware, software, columns, standard, methods and user guides/SOPs to enable analytical insights from day one. The analytical methods have been developed according to FDA & EMA guidelines.

Item no.

PAT0050

Item no.

PAT0050
PATfix® MALS detector

Documents

The perfect detector when your drug substance is a particle.

Item no.

PAT0033

Item no.

PAT0033

Overview

Genetic therapies are providing new hope for vaccines as well as previously incurable diseases, but they also present new challenges for process development and control. The sheer size and complexity of products like pDNA, mRNA and AAV present a new challenge for "at-line" analytics, like distinguishing sc/oc/lin pDNA or empty from full AAV capsids.

At Sartorius BIA Separations, we are passionate about providing the best solutions for gene therapy purification, by providing a modality-specific platform for analysis and in-process control of new generation gene therapy products.

To achieve this, we have built our platform on 4 key pillars:

Software

Process development and production of gene therapy products brings together people with different skills and specializations, hence PATfix^® software is built to address the needs and solve challenges of each. An integral part of the PATfix^® value proposition, the PATfix^® software strips away the complexity of chromatography at the day-to-day operational level, while retaining it for higher level tasks.

CIMac™ columns

CIMac™ analytical columns, are a perfect tool for chromatography of large gene therapy products due to convective laminar flow, a large accessible surface area required for product binding and a variety of surface chemistries. These characteristics give us the versatility to customize the PATfix^® plattform for a broad range of gene therapy products.

Hardware

Featuring bio-inert ceramic pump heads, and flow rates up to 10 mL/min (quaternary pump), PATfix^® is designed to extract maximum analytical information for a wide range of biological products. A highly sensitive, multi-wavelength UV detector, as well as a fluorescence detector, capture component peaks, even with the steepest gradients.

Know-how

It's not just about the individual building blocks, it's knowing exactly which blocks are required and how they need to work together to achieve their stated goal – provide analytical insight at every step of gene therapy process development and production. Gaining this level of insight requires a lot of trial and error to perfect. We have developed and transferred methods for both analytics and production of gene therapeutics to many customers. The experience gained on such a variety of products and projects has allowed us to develop a set of chromatographic methods, that can encompass a variety of products and can be applied to key steps of PD and production.

Documents

Language: